断続的な断食は脳プロテオームを再プログラムし,血管性認知症におけるシナプス変性や認知障害を予防します
Nishat I Tabassum1,2, Sharmelee Selvaraji3,4, Yibo Fan1,2
1Department of Microbiology, Anatomy, Physiology and Pharmacology, School of Agriculture, Biomedicine and Environment, La Trobe University, Melbourne, Australia.
Theranostics
|August 27, 2025
まとめ
断続的な断食 (IF) は,シナプスの整合性と機能を維持することによって,血管性認知症の低下を防ぎます. この研究では,IFは代謝の再プログラムと神経炎症の減少によってシナプス回復力を高めることが示されています.
科学分野:
- 神経科学
- 血管生物学
- 代謝に関する研究
背景:
- 血管性認知症 (VaD) は慢性脳低血流 (CCH) に起因し,シナプス変性や認知機能低下を引き起こします.
- 血管の問題とシナプス喪失を結びつけるメカニズムは完全に理解されていません.
- 断続的な断食 (IF) は潜在的な介入ですが,ヴァーディのシナプス健康への影響は不明です.
研究 の 目的:
- CCHによるシナプス変性および認知障害に対するIFの影響を調査する.
- VaDのマウスモデルにおけるIFの神経保護効果の基礎となる分子メカニズムを探求する.
主な方法:
- マウスにおける双極常動脈狭窄 (BCAS) によって誘発された慢性脳低血流 (CCH).
- BCAS誘導前に実施された断続的な断食 (毎日16時間).
- 認知機能はバーンズ迷路を用いて評価され,シナプス整合性は電子顕微鏡,免疫ブロッティング,免疫ヒストケミストリーで評価され,ヒポカンパのタンパク質解析が行われました.
主要な成果:
- BCASマウスの認知機能とシナプス密度を保ち,空間記憶の欠陥を予防した.
- 電子顕微鏡では,基底構造の変化なしにシナプス保存が確認され,重要なシナプスタンパク質のレベルは変化しなかった.
- プロテオミク解析により,IFはシナプス安定剤を調節し,GABAergicシグナル伝達を強化し,多相神経保護効果で神経炎症を抑制することが明らかになった.
結論:
- 断続的な断食 (IF) は,血管性認知症 (VaD) のシナプス回復力の強力な調節剤として作用します.
- IFはシナプス構造を保護し,炎症性シナプス損失を抑制し,代謝を再プログラムし,血管性認知障害に対する非薬理学的戦略を提供します.
関連する概念動画
01:24Metabolic States of the Body: Fasting and Starvation
1.8K
During the initial hours of fasting, the body uses up its glycogen stores as an energy source. Once these glycogen reserves are depleted, the body begins breaking down stored triglycerides and structural proteins. During this stage, glycerol becomes a key substrate for gluconeogenesis, while free fatty acids undergo beta-oxidation to provide energy for tissues, such as skeletal muscle. In the fasting state, the body spares protein breakdown as much as possible to conserve muscle and structural...
1.8K
01:22Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260
01:26Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666
01:18Metabolic States of the Body: The Postabsorptive State
541
The postabsorptive state usually starts about four hours after a meal and lasts until the next meal is eaten. During this time, the digestive system stops absorbing nutrients, and the body uses stored energy reserves to maintain stable blood glucose levels.
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
541